Diksha Polymers debuted on the BSE SME platform at a slight premium, opening at Rs 114.50 against its IPO price of Rs 112. The Rs 17.9-cror...

India's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...

When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...

Currently, India’s FTA utilisation rate hovers around 25% compared to 70-80% in developed economies.

Nikhil Kamath water business idea: India's rapid growth in water-intensive sectors like agriculture, nuclear energy, pharmaceuticals, and d...

As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...

The allotment is expected to be finalised on June 22, while the shares are scheduled to list on the BSE SME platform on June 24.

Geopolitical shifts and the drive for self-reliance are creating long-term investment opportunities in India's defence and electrification ...

The IPO market will see limited activity next week, with only two SME issues, Liotech Industries and Leapfrog Engineering, opening on June ...

On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...

After 12 years at the helm, Prime Minister Narendra Modi reflects on a transformative journey filled with key reforms that have altered Ind...

India may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...

India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Sebi has approved IPOs for Renny Strips, Krishna Buildspace, and Rodec Pharmaceuticals. Renny Strips, a structural steel manufacturer, inte...